Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia (EASE)
Primary Purpose
Acute Leukemia
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
EASE
Sponsored by
About this trial
This is an interventional treatment trial for Acute Leukemia focused on measuring acute leukemia, traumatic stress, quality of life, symptom burden, psychosocial oncology, palliative care, intervention, hematological malignancies, supportive care
Eligibility Criteria
Inclusion Criteria:
- new or relapsed diagnosis of acute leukemia (an amendment to allow recruitment of relapsed patients was approved on 24-Sep-2015, although no relapsed patients were ultimately recruited)
- will be receiving induction chemotherapy with curative intent and within 1 month of diagnosis and/or admission to hospital at the Princess Margaret Cancer Centre
- age ≥ 18 years
- fluency in English
- no cognitive impairment indicated in the medical record, communicated by the hematology clinical team, or determined by research staff at recruitment.
Exclusion Criteria:
- inability to pass the cognitive screening test (Short Orientation-Memory Concentration Test [SOMC] score <20)
- actively receiving psychological/psychiatric counseling or palliative care services from the Department of Psychosocial Oncology and Palliative Care (POPC), now called the Department of Supportive Care, at the Princess Margaret Cancer Centre at the time of recruitment to this study
Sites / Locations
- Princess Margaret Cancer Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
EASE
Usual Care
Arm Description
Patients assigned to the intervention arm will receive 8 - 12 psychotherapy sessions lasting 30 - 60 minutes each, delivered by a trained therapist at our center. Patients will receive specialized symptom control from a nurse/physician team in our Palliative Care Service, when indicated by routine symptom screening.
Usual care
Outcomes
Primary Outcome Measures
Stanford Acute Stress Reaction Questionnaire (SASRQ)
A 30-item reliable and valid self-report measure of traumatic stress symptoms.
Secondary Outcome Measures
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp)
A 40-item reliable and valid self-report measure of overall quality of life, including 12 items that assess spiritual well-being, spiritual meaning and peace, and faith.
Beck Depression Inventory-II (BDI-II)
A 21-item reliable and valid self-report measure of the intensity of depressive symptoms, consistent with the DSM-V criteria for major depressive disorder.
Brief Pain Inventory short form (BPI-sf)
A 9-item reliable and valid self-report measure that assesses pain severity and the impact of pain on daily functioning.
Memorial Symptom Assessment Scale (MSAS)
A 32-item reliable and valid self-report inventory assessing the presence and severity of 26 common physical symptoms and 6 psychological symptoms of cancer. The scale has been adapted to reduce burden. A shortened version that omits frequency of symptoms and treatment, and satisfaction with treatment for each symptom was used.
Brief Experiences in Close Relationships Scale (ECR-M16)
A 16-item reliable and valid self-report measure of attachment security.
FAMCARE-P16
A 16-item reliable and valid self-report measure of patient satisfaction with healthcare providers.
Clinical Evaluation Questionnaire (CEQ)
A 7-item measure developed for this study to evaluate the extent to which patients felt emotionally supported by the clinical services provided.
Edmonton Symptom Assessment System - Acute Leukemia (ESAS-AL)
A 14-item symptom severity assessment measure adapted for patients with acute leukemia to include prevalent and treatable symptoms in this population: mouth sores, diarrhea, itching, constipation, and insomnia. ESAS-AL was used as a screening tool as part of the clinical intervention, and was added as an outcome later in the trial (13-Apr-2016).
Full Information
NCT ID
NCT02353559
First Posted
January 28, 2015
Last Updated
September 26, 2019
Sponsor
University Health Network, Toronto
Collaborators
Canadian Cancer Society (CCS)
1. Study Identification
Unique Protocol Identification Number
NCT02353559
Brief Title
Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia
Acronym
EASE
Official Title
Emotion And Symptom-focused Engagement (EASE): A Randomized Pilot Trial of an Intervention for Individuals With Acute Leukemia
Study Type
Interventional
2. Study Status
Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
March 2015 (Actual)
Primary Completion Date
November 2016 (Actual)
Study Completion Date
November 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
Collaborators
Canadian Cancer Society (CCS)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to test the feasibility of an individual psychological and physical symptom intervention, called Emotion And Symptom-focused Engagement (EASE), to reduce traumatic stress and physical symptom burden in individuals newly diagnosed with acute leukemia.
Detailed Description
This study involves the pilot-testing of a newly developed, brief manualized individual psychotherapy and physical symptom control intervention, called Emotion And Symptom-focused Engagement (EASE), to reduce traumatic stress and physical symptom burden in individuals newly diagnosed with acute leukemia. The purpose of this study is to conduct a two-arm randomized pilot trial (RPT) to test the feasibility, acceptability, and preliminary efficacy of EASE against usual care (UC) for the reduction of traumatic stress and physical symptom burden in patients with acute leukemia. Usual care for individuals with acute leukemia treated at the Princess Margaret Cancer Centre includes referral for non-standardized, and primarily instrumental, psychosocial care and palliative care service as needed.
The design will be an unblinded RPT consisting of two conditions (EASE and UC), with a baseline assessment and follow-ups at 4, 8, and 12 weeks. The trial will take place at the Princess Margaret Cancer Centre, University Health Network; a comprehensive cancer center in Toronto, Canada. Participants will be newly diagnosed with acute leukemia, within one month of diagnosis and/or admission to hospital for treatment with curative intent.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Leukemia
Keywords
acute leukemia, traumatic stress, quality of life, symptom burden, psychosocial oncology, palliative care, intervention, hematological malignancies, supportive care
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
47 (Actual)
8. Arms, Groups, and Interventions
Arm Title
EASE
Arm Type
Experimental
Arm Description
Patients assigned to the intervention arm will receive 8 - 12 psychotherapy sessions lasting 30 - 60 minutes each, delivered by a trained therapist at our center. Patients will receive specialized symptom control from a nurse/physician team in our Palliative Care Service, when indicated by routine symptom screening.
Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Behavioral
Intervention Name(s)
EASE
Intervention Description
EASE includes psychotherapeutic (EASE-psy) and physical symptom control (EASE-phys) components.
Primary Outcome Measure Information:
Title
Stanford Acute Stress Reaction Questionnaire (SASRQ)
Description
A 30-item reliable and valid self-report measure of traumatic stress symptoms.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp)
Description
A 40-item reliable and valid self-report measure of overall quality of life, including 12 items that assess spiritual well-being, spiritual meaning and peace, and faith.
Time Frame
12 weeks
Title
Beck Depression Inventory-II (BDI-II)
Description
A 21-item reliable and valid self-report measure of the intensity of depressive symptoms, consistent with the DSM-V criteria for major depressive disorder.
Time Frame
12 weeks
Title
Brief Pain Inventory short form (BPI-sf)
Description
A 9-item reliable and valid self-report measure that assesses pain severity and the impact of pain on daily functioning.
Time Frame
12 weeks
Title
Memorial Symptom Assessment Scale (MSAS)
Description
A 32-item reliable and valid self-report inventory assessing the presence and severity of 26 common physical symptoms and 6 psychological symptoms of cancer. The scale has been adapted to reduce burden. A shortened version that omits frequency of symptoms and treatment, and satisfaction with treatment for each symptom was used.
Time Frame
12 weeks
Title
Brief Experiences in Close Relationships Scale (ECR-M16)
Description
A 16-item reliable and valid self-report measure of attachment security.
Time Frame
12 weeks
Title
FAMCARE-P16
Description
A 16-item reliable and valid self-report measure of patient satisfaction with healthcare providers.
Time Frame
12 weeks
Title
Clinical Evaluation Questionnaire (CEQ)
Description
A 7-item measure developed for this study to evaluate the extent to which patients felt emotionally supported by the clinical services provided.
Time Frame
12 weeks
Title
Edmonton Symptom Assessment System - Acute Leukemia (ESAS-AL)
Description
A 14-item symptom severity assessment measure adapted for patients with acute leukemia to include prevalent and treatable symptoms in this population: mouth sores, diarrhea, itching, constipation, and insomnia. ESAS-AL was used as a screening tool as part of the clinical intervention, and was added as an outcome later in the trial (13-Apr-2016).
Time Frame
24 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
new or relapsed diagnosis of acute leukemia (an amendment to allow recruitment of relapsed patients was approved on 24-Sep-2015, although no relapsed patients were ultimately recruited)
will be receiving induction chemotherapy with curative intent and within 1 month of diagnosis and/or admission to hospital at the Princess Margaret Cancer Centre
age ≥ 18 years
fluency in English
no cognitive impairment indicated in the medical record, communicated by the hematology clinical team, or determined by research staff at recruitment.
Exclusion Criteria:
inability to pass the cognitive screening test (Short Orientation-Memory Concentration Test [SOMC] score <20)
actively receiving psychological/psychiatric counseling or palliative care services from the Department of Psychosocial Oncology and Palliative Care (POPC), now called the Department of Supportive Care, at the Princess Margaret Cancer Centre at the time of recruitment to this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gary Rodin, MD FRCPC
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Camilla Zimmermann, MD PhD FRCPC
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Princess Margaret Cancer Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2M9
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
22081505
Citation
Rodin G, Yuen D, Mischitelle A, Minden MD, Brandwein J, Schimmer A, Marmar C, Gagliese L, Lo C, Rydall A, Zimmermann C. Traumatic stress in acute leukemia. Psychooncology. 2013 Feb;22(2):299-307. doi: 10.1002/pon.2092. Epub 2011 Nov 13.
Results Reference
background
PubMed Identifier
24559581
Citation
Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014 May 17;383(9930):1721-30. doi: 10.1016/S0140-6736(13)62416-2. Epub 2014 Feb 19.
Results Reference
background
PubMed Identifier
23490030
Citation
Zimmermann C, Yuen D, Mischitelle A, Minden MD, Brandwein JM, Schimmer A, Gagliese L, Lo C, Rydall A, Rodin G. Symptom burden and supportive care in patients with acute leukemia. Leuk Res. 2013 Jul;37(7):731-6. doi: 10.1016/j.leukres.2013.02.009. Epub 2013 Mar 11.
Results Reference
background
PubMed Identifier
23352641
Citation
Nissim R, Zimmermann C, Minden M, Rydall A, Yuen D, Mischitelle A, Gagliese L, Schimmer A, Rodin G. Abducted by the illness: a qualitative study of traumatic stress in individuals with acute leukemia. Leuk Res. 2013 May;37(5):496-502. doi: 10.1016/j.leukres.2012.12.007. Epub 2013 Jan 24.
Results Reference
background
PubMed Identifier
24705856
Citation
Nissim R, Rodin G, Schimmer A, Minden M, Rydall A, Yuen D, Mischitelle A, Fitzgerald P, Lo C, Gagliese L, Zimmermann C. Finding new bearings: a qualitative study on the transition from inpatient to ambulatory care of patients with acute myeloid leukemia. Support Care Cancer. 2014 Sep;22(9):2435-43. doi: 10.1007/s00520-014-2230-3. Epub 2014 Apr 5.
Results Reference
background
PubMed Identifier
16802127
Citation
Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G. Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer. 2006 Oct;14(10):982-7. doi: 10.1007/s00520-006-0093-y. Epub 2006 Jun 27.
Results Reference
background
PubMed Identifier
28665521
Citation
Rodin G, Deckert A, Tong E, Le LW, Rydall A, Schimmer A, Marmar CR, Lo C, Zimmermann C. Traumatic stress in patients with acute leukemia: A prospective cohort study. Psychooncology. 2018 Feb;27(2):515-523. doi: 10.1002/pon.4488. Epub 2017 Aug 10.
Results Reference
background
PubMed Identifier
30535882
Citation
Shaulov A, Rodin G, Popovic G, Caraiscos VB, Le LW, Rydall A, Schimmer AD, Zimmermann C. Pain in patients with newly diagnosed or relapsed acute leukemia. Support Care Cancer. 2019 Aug;27(8):2789-2797. doi: 10.1007/s00520-018-4583-5. Epub 2018 Dec 8.
Results Reference
background
PubMed Identifier
31001692
Citation
Rodin G, Malfitano C, Rydall A, Schimmer A, Marmar CM, Mah K, Lo C, Nissim R, Zimmermann C. Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia. Support Care Cancer. 2020 Jan;28(1):163-176. doi: 10.1007/s00520-019-04723-2. Epub 2019 Apr 17.
Results Reference
result
Learn more about this trial
Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia
We'll reach out to this number within 24 hrs